Novel alpha-glucan and application thereof

The invention provides a novel alpha-glucan and application of the novel alpha-glucan. The alpha-glucan is homologous series of polysaccharides and has the same alpha-1, 4-glucan main chain, different branching degrees and glucose and glucuronic acid side chains. A glucuronic acid side chain is a specific structural fragment of the alpha-glucan and also makes an important contribution to the biological activity of the alpha-glucan. The alpha-glucan provided by the invention is rich in source, stable in structure and high in purity, has remarkable immunoregulation and anti-tumor activity, and is expected to be developed into drugs for improving or treating immune-related body dysfunction and/or resisting tumors..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 10. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

ZHAO FENG [VerfasserIn]
WANG CHUNHUA [VerfasserIn]
HOU GUIGE [VerfasserIn]
XIN WENYU [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23L: Foods, foodstuffs, or non-alcoholic beverages, not (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C08B: Polysaccharides; derivatives thereof (polysaccharid (...)
cet
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-10, Last update posted on www.tib.eu: 2024-04-22, Last updated: 2024-04-26

Patentnummer:

CN117024626

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA003856267